Chaim Hurvitz is Director at NRX Pharmaceuticals, Inc. (NRXP). They have made 2 open-market trades across 1 company since 2022, most recently 2023-08-30.
CIK 0001630542
2 open-market purchases totalling $1.0M since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NRXP | 570,000 | $1.5M |
Shares reported on the most recent Form 4, priced at the 2023-09-11 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.